While it may not be ‘politically correct’ to discuss, the majority of the world’s drug developments and innovation are underwritten by the United States (U.S.).
Posts published by “Paul Brennan”
Paul Brennan is a Grit DAily contributor and president/CEO of NervGen Pharma Corp., a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. He can be reached at pbrennan@nervgen.com.
Despite the immense challenges that have arisen in developing Alzheimer’s disease (“Alzheimer’s”) drugs and the high-profile failures, the economics of Alzheimer’s drug development are golden.…
Pharma and biotech companies have demonstrated a rapid and powerful response to the COVID-19 pandemic with biopharmaceutical innovators leading the charge in the fight. A…
Defining a Successful Biotech Entrepreneur
With its ability to bring its first vaccine candidates from concept into clinical development in less than three months, BioNTech is making global waves as…